Yale tests 'Magic Mushroom' microdoses on brain and mood
NCT ID NCT07449351
Summary
This small pilot study aims to understand how taking very small, non-psychedelic doses of psilocybin (from 'magic mushrooms') over 30 days affects mood, thinking skills, and brain activity. Researchers will compare 20 healthy adults who have never used psychedelics, giving some the microdose and others a placebo. The goal is to gather basic knowledge to see if this approach could someday help people with conditions like depression.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PSYCHEDELIC MICRODOSING EFFECTS ON MOOD, COGNITION, SUBJECTIVE WELL-BEING AND MRI are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Olin Neuropsychiatry Research Center
Hartford, Connecticut, 06106, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.